Man-Chiu Poon

30PUBLICATIONS
71CO-AUTHORS
HaematologyCardiology (incl. cardiovascular diseases)Epidemiological methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 17, 2026
Long-term experience with emicizumab in people with hemophilia A in the Canadian Bleeding Disorders Registry.

|Jan 29, 2026
The International/Canadian hereditary angioedema guideline.

Stephen Betschel, Karen Binkley, Rozita Borici-Mazi

|Dec 26, 2024
Investigation of a hemophilia family with one female hemophilia A patient and 12 male hemophilia A patients.

Jie Wang, Qiang Li, Yan Cheng

|Dec 25, 2024
Real-world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center.

Qianqian Mao, Zhenping Chen, Guoqing Liu

|Jun 24, 2024
Low-dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor-titer below 200 BU/mL.

Zhengping Li, Jie Sun, Zekun Li

|Jun 09, 2024
Reduced doses of emicizumab achieve good efficacy: Results from a national-wide multicentre real-world study in China.

Yuan Xu, Ying Wang, Runhui Wu

Pageof 5

Frequent Collaborators

6 joint publications

Runhui Wu

5 joint publications

Adrienne Lee

5 joint publications

Feng Xue

5 joint publications

Xiaoling Cheng